Full-Time
Posted on 12/20/2024
Develops orthopedic and reconstructive medical devices
Mid, Senior
No H1B Sponsorship
Austin, TX, USA
You match the following ENOVIS's candidate preferences
Employers are more likely to interview you if you match these preferences:
Enovis develops medical technology solutions aimed at improving patient outcomes and restoring mobility. The company operates in two main segments: Prevention & Recovery, which offers orthopedic solutions like bracing products and therapy systems for rehabilitation and sports medicine, and Reconstructive, which focuses on implant products for various joints and minimally invasive surgical tools. Enovis's products, including well-known brands like DonJoy and Aircast, are designed to address specific medical needs such as pain management and bone growth stimulation. What sets Enovis apart from competitors is its commitment to continuous improvement through the Enovis Growth Excellence (EGX) system, which enhances operations and customer satisfaction. The company's goal is to innovate in the medical technology field to create better outcomes for patients and healthcare providers globally.
Company Size
1,001-5,000
Company Stage
IPO
Total Funding
N/A
Headquarters
Wilmington, Delaware
Founded
2022
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Paid Vacation
Paid Sick Leave
Paid Holidays
Legal Services
Enovis appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies.
Confluence Investment Management LLC makes new $3.49 million investment in Enovis Co. (NYSE:ENOV).
Medtech company Enovis Corp. has unveiled its Scandinavian Total Ankle Replacement (STAR Ankle) upgrade, which is reportedly the first FDA-cleared mobile bearing ankle system with a polyethylene (PE) insert doped with vitamin E.
Dynamic Technology Lab Private Ltd makes new $1.05 million investment in Enovis Co. (NYSE:ENOV).
Enovis to participate in the 43rd Annual J.P. Morgan Healthcare Conference.
Recognizing this important shift, Enovis(TM) has created a comprehensive eBook to help clinicians navigate the world of cash-pay services.
GAMMA Investing LLC makes new investment in Enovis Co. (NYSE:ENOV).
Enovis introduces STAR Ankle, with e+ Polyethylene.
Enovis (NYSE: ENOV) announced today that it appointed Davide Visentin as the new president of its International Surgical business.
Matt Trerotola became the CEO of Colfax Corporation (
Enovis announced the expansion of its EMPOWR Revision Knee system to include EMPOWR Cones.